{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:05:41Z","timestamp":1753437941727,"version":"3.33.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Provincial Natural Science Foundation Project","award":["2023J01093"],"award-info":[{"award-number":["2023J01093"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10515-3","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T09:43:04Z","timestamp":1737798184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The association between Chlamydia pneumoniae infection and prognosis in lung cancer patients: a prospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Maolin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zishan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinman","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuezhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"issue":"3","key":"10515_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10515_CR2","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/annonc\/mdz117","volume":"30","author":"U Pastorino","year":"2019","unstructured":"Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019;30(7):1162\u20139.","journal-title":"Ann Oncol"},{"issue":"6","key":"10515_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","volume":"382","author":"HJ de Koning","year":"2020","unstructured":"de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-Cancer mortality with volume CT screening in a Randomized Trial. N Engl J Med. 2020;382(6):503\u201313.","journal-title":"N Engl J Med"},{"issue":"10125","key":"10515_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u201375.","journal-title":"Lancet"},{"issue":"6","key":"10515_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.6004\/jnccn.2013.0084","volume":"11","author":"DS Ettinger","year":"2013","unstructured":"Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, et al. Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw. 2013;11(6):645\u201353. quiz 53.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10515_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1513\/pats.201107-042ST","volume":"8","author":"WD Travis","year":"2011","unstructured":"Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 2011;8(5):381\u20135.","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"10515_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/JTO.0b013e3181c41e8d","volume":"5","author":"J Subramanian","year":"2010","unstructured":"Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, et al. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis. J Thorac Oncol. 2010;5(1):23\u20138.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10515_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0720-048X(02)00287-5","volume":"45","author":"CJ Beadsmoore","year":"2003","unstructured":"Beadsmoore CJ, Screaton NJ. Classification, staging and prognosis of lung cancer. Eur J Radiol. 2003;45(1):8\u201317.","journal-title":"Eur J Radiol"},{"issue":"2","key":"10515_CR9","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180\u201390.","journal-title":"Lancet Glob Health"},{"key":"10515_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/abr.abr_182_17","volume":"7","author":"M Keikha","year":"2018","unstructured":"Keikha M, Esfahani BN. The relationship between Tuberculosis and Lung Cancer. Adv Biomed Res. 2018;7:58.","journal-title":"Adv Biomed Res"},{"key":"10515_CR11","doi-asserted-by":"publisher","first-page":"e2015052","DOI":"10.4178\/epih\/e2015052","volume":"37","author":"JM Bae","year":"2015","unstructured":"Bae JM, Kim EH. Human papillomavirus infection and risk of lung cancer in never-smokers and women: an \u2018adaptive\u2019 meta-analysis. Epidemiol Health. 2015;37:e2015052.","journal-title":"Epidemiol Health"},{"issue":"8","key":"10515_CR12","first-page":"3235","volume":"32","author":"K Syrjanen","year":"2012","unstructured":"Syrjanen K. Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res. 2012;32(8):3235\u201350.","journal-title":"Anticancer Res"},{"issue":"3","key":"10515_CR13","doi-asserted-by":"publisher","first-page":"e0193232","DOI":"10.1371\/journal.pone.0193232","volume":"13","author":"J An","year":"2018","unstructured":"An J, Kim JW, Shim JH, Han S, Yu CS, Choe J, et al. Chronic hepatitis B infection and non-hepatocellular cancers: a hospital registry-based, case-control study. PLoS ONE. 2018;13(3):e0193232.","journal-title":"PLoS ONE"},{"issue":"13","key":"10515_CR14","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.7314\/APJCP.2015.16.13.5285","volume":"16","author":"JW Peng","year":"2015","unstructured":"Peng JW, Liu DY, Lin GN, Xiao JJ, Xia ZJ. Hepatitis B Virus infection is Associated with poor prognosis in patients with Advanced non Small Cell Lung Cancer. Asian Pac J Cancer Prev. 2015;16(13):5285\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"10515_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.lungcan.2011.12.008","volume":"76","author":"ME Heuvers","year":"2012","unstructured":"Heuvers ME, Aerts JG, Hegmans JP, Veltman JD, Uitterlinden AG, Ruiter R, et al. History of tuberculosis as an independent prognostic factor for lung cancer survival. Lung Cancer. 2012;76(3):452\u20136.","journal-title":"Lung Cancer"},{"issue":"5","key":"10515_CR16","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.ajpath.2012.07.032","volume":"181","author":"DW Wu","year":"2012","unstructured":"Wu DW, Tsai LH, Chen PM, Lee MC, Wang L, Chen CY, et al. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer. Am J Pathol. 2012;181(5):1796\u2013806.","journal-title":"Am J Pathol"},{"issue":"Suppl 2","key":"10515_CR17","first-page":"e112","volume":"52","author":"X Hua-Feng","year":"2015","unstructured":"Hua-Feng X, Yue-Ming W, Hong L, Junyi D. A meta-analysis of the association between Chlamydia pneumoniae infection and lung cancer risk. Indian J Cancer. 2015;52(Suppl 2):e112\u20135.","journal-title":"Indian J Cancer"},{"issue":"5","key":"10515_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ejca.2010.11.003","volume":"47","author":"P Zhan","year":"2011","unstructured":"Zhan P, Suo LJ, Qian Q, Shen XK, Qiu LX, Yu LK, et al. Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer. 2011;47(5):742\u20137.","journal-title":"Eur J Cancer"},{"issue":"4","key":"10515_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7326\/0003-4819-116-4-273","volume":"116","author":"P Saikku","year":"1992","unstructured":"Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992;116(4):273\u20138.","journal-title":"Ann Intern Med"},{"key":"10515_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2377-13-183","volume":"13","author":"J Chen","year":"2013","unstructured":"Chen J, Zhu M, Ma G, Zhao Z, Sun Z. Chlamydia pneumoniae infection and cerebrovascular disease: a systematic review and meta-analysis. BMC Neurol. 2013;13:183.","journal-title":"BMC Neurol"},{"issue":"3","key":"10515_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/ijs.12248","volume":"9","author":"X Su","year":"2014","unstructured":"Su X, Chen HL. Chlamydia pneumoniae infection and cerebral infarction risk: a meta-analysis. Int J Stroke. 2014;9(3):356\u201364.","journal-title":"Int J Stroke"},{"issue":"7190","key":"10515_CR22","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/bmj.318.7190.1035","volume":"318","author":"DP Strachan","year":"1999","unstructured":"Strachan DP, Carrington D, Mendall MA, Ballam L, Morris J, Butland BK, et al. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study. BMJ. 1999;318(7190):1035\u20139.","journal-title":"BMJ"},{"issue":"1","key":"10515_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1186\/s12885-020-07418-8","volume":"20","author":"X Xu","year":"2020","unstructured":"Xu X, Liu Z, Xiong W, Qiu M, Kang S, Xu Q, et al. Combined and interaction effect of chlamydia pneumoniae infection and smoking on lung cancer: a case-control study in Southeast China. BMC Cancer. 2020;20(1):903.","journal-title":"BMC Cancer"},{"issue":"1","key":"10515_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13027-022-00425-3","volume":"17","author":"NM Premachandra","year":"2022","unstructured":"Premachandra NM, Jayaweera J. Chlamydia pneumoniae infections and development of lung cancer: systematic review. Infect Agent Cancer. 2022;17(1):11.","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"10515_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1165\/ajrcmb.19.5.3072","volume":"19","author":"V Redecke","year":"1998","unstructured":"Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol. 1998;19(5):721\u20137.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Suppl 3","key":"10515_CR26","doi-asserted-by":"publisher","first-page":"S473","DOI":"10.1086\/315612","volume":"181","author":"CA Gaydos","year":"2000","unstructured":"Gaydos CA. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis. 2000;181(Suppl 3):S473\u20138.","journal-title":"J Infect Dis"},{"issue":"5","key":"10515_CR27","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.celrep.2019.01.006","volume":"26","author":"PK Zadora","year":"2019","unstructured":"Zadora PK, Chumduri C, Imami K, Berger H, Mi Y, Selbach M, et al. Integrated Phosphoproteome and Transcriptome Analysis reveals Chlamydia-Induced epithelial-to-mesenchymal transition in host cells. Cell Rep. 2019;26(5):1286\u2013302. e8.","journal-title":"Cell Rep"},{"issue":"12","key":"10515_CR28","doi-asserted-by":"publisher","first-page":"e0145198","DOI":"10.1371\/journal.pone.0145198","volume":"10","author":"JU Igietseme","year":"2015","unstructured":"Igietseme JU, Omosun Y, Stuchlik O, Reed MS, Partin J, He Q, et al. Role of epithelial-mesenchyme transition in Chlamydia Pathogenesis. PLoS ONE. 2015;10(12):e0145198.","journal-title":"PLoS ONE"},{"issue":"10","key":"10515_CR29","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1128\/IAI.71.10.5814-5822.2003","volume":"71","author":"MM Gencay","year":"2003","unstructured":"Gencay MM, Tamm M, Glanville A, Perruchoud AP, Roth M. Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor. Infect Immun. 2003;71(10):5814\u201322.","journal-title":"Infect Immun"},{"issue":"5","key":"10515_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1078\/1438-4221-00274","volume":"293","author":"C Wahl","year":"2003","unstructured":"Wahl C, Maier S, Marre R, Essig A. Chlamydia pneumoniae induces the expression of inhibitor of apoptosis 2 (c-IAP2) in a human monocytic cell line by an NF-kappaB-dependent pathway. Int J Med Microbiol. 2003;293(5):377\u201381.","journal-title":"Int J Med Microbiol"},{"issue":"1","key":"10515_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1465-9921-6-51","volume":"6","author":"H Wissel","year":"2005","unstructured":"Wissel H, Schulz C, Koehne P, Richter E, Maass M, Rudiger M. Chlamydophila pneumoniae induces expression of toll-like receptor 4 and release of TNF-alpha and MIP-2 via an NF-kappaB pathway in rat type II pneumocytes. Respir Res. 2005;6(1):51.","journal-title":"Respir Res"},{"issue":"1","key":"10515_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1600-065X.2012.01095.x","volume":"246","author":"AS Baldwin","year":"2012","unstructured":"Baldwin AS. Regulation of cell death and autophagy by IKK and NF-kappaB: critical mechanisms in immune function and cancer. Immunol Rev. 2012;246(1):327\u201345.","journal-title":"Immunol Rev"},{"issue":"6","key":"10515_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ijmm.2015.04.006","volume":"305","author":"A Sarkar","year":"2015","unstructured":"Sarkar A, Moller S, Bhattacharyya A, Behnen M, Rupp J, van Zandbergen G, et al. Mechanisms of apoptosis inhibition in Chlamydia pneumoniae-infected neutrophils. Int J Med Microbiol. 2015;305(6):493\u2013500.","journal-title":"Int J Med Microbiol"},{"key":"10515_CR34","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1038\/ncomms6201","volume":"5","author":"E Gonzalez","year":"2014","unstructured":"Gonzalez E, Rother M, Kerr MC, Al-Zeer MA, Abu-Lubad M, Kessler M, et al. Chlamydia infection depends on a functional MDM2-p53 axis. Nat Commun. 2014;5:5201.","journal-title":"Nat Commun"},{"issue":"4","key":"10515_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.intimp.2004.12.010","volume":"5","author":"Y Mamata","year":"2005","unstructured":"Mamata Y, Hakki A, Yamamoto Y, Newton C, Klein TW, Pross S, et al. Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells. Int Immunopharmacol. 2005;5(4):749\u201356.","journal-title":"Int Immunopharmacol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10515-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10515-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10515-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T09:43:09Z","timestamp":1737798189000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10515-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10515"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10515-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics committee of Fujian Medical University (Fuzhou, China). The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"119"}}